Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax

Haematologica. 2023 Nov 1;108(11):3142-3147. doi: 10.3324/haematol.2022.282637.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Azacitidine / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Child
  • Humans
  • Leukemia* / drug therapy
  • Leukemia, Myeloid, Acute* / drug therapy
  • Sulfonamides / therapeutic use

Substances

  • Azacitidine
  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides